Equities

Novartis AG

0QM7:LSE

Novartis AG

  • Price (CHF)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
0QM7:LSE since
announced
Transaction
value
IFM Due IncAnnounced13 Mar 202413 Mar 2024Announced-100.00%835.00m
Cytokinetics IncRumoured08 Jan 202408 Jan 2024Rumoured-100.00%--
Calypso Biotech BVAnnounced08 Jan 202408 Jan 2024Announced-100.00%425.00m
SanReno TherapeuticsDeal completed05 Jan 202405 Jan 2024Deal completed-100.00%--
DTx Pharma IncDeal completed17 Jul 202317 Jul 2023Deal completed-100.00%500.00m
Data delayed at least 20 minutes, as of Dec 30 1899.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.